proline has been researched along with Porphyria Cutanea Tarda in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chaparro, M; García-Buey, L; Rojo, E | 1 |
Aguilera, P; Laguno, M; To-Figueras, J | 1 |
2 other study(ies) available for proline and Porphyria Cutanea Tarda
Article | Year |
---|---|
Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn´s Disease.
Topics: Aminoisobutyric Acids; Antibodies, Monoclonal, Humanized; Benzimidazoles; Crohn Disease; Cyclopropanes; Gastrointestinal Agents; Hepatitis C; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Porphyria Cutanea Tarda; Proline; Pyrrolidines; Quinoxalines; Sulfonamides | 2020 |
Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda.
Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Porphyria Cutanea Tarda; Proline; Remission Induction | 2014 |